ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
ALDH8A1 | Aldehyde dehydrogenase 8 family, member A1 | | | | | | Group enriched |
ALDH9A1 | Aldehyde dehydrogenase 9 family, member A1 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ALG11 | ALG11, alpha-1,2-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ALG2 | ALG2, alpha-1,3/1,6-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ALOX12 | Arachidonate 12-lipoxygenase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
ALOX5 | Arachidonate 5-lipoxygenase | Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
ALPK1 | Alpha-kinase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
AMACR | Alpha-methylacyl-CoA racemase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
ANO1 | Anoctamin 1, calcium activated chloride channel | FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANO4 | Anoctamin 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
ANPEP | Alanyl (membrane) aminopeptidase | CD markers Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
AOX1 | Aldehyde oxidase 1 | Enzymes Plasma proteins
| | | | | Tissue enhanced |
APH1A | APH1A gamma secretase subunit | Predicted membrane proteins
| | | | | Expressed in all |
APLP1 | Amyloid beta (A4) precursor-like protein 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
APLP2 | Amyloid beta (A4) precursor-like protein 2 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APOC2 | Apolipoprotein C-II | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOC4-APOC2 | APOC4-APOC2 readthrough (NMD candidate) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOL1 | Apolipoprotein L, 1 | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APOL2 | Apolipoprotein L, 2 | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
APP | Amyloid beta (A4) precursor protein | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
AQP1 | Aquaporin 1 (Colton blood group) | Blood group antigen proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
AQP1 | Uncharacterized protein | Predicted membrane proteins
| | | | | Not detected |
AQP12A | Aquaporin 12A | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AQP12B | Aquaporin 12B | Predicted membrane proteins
| | | | | Tissue enriched |
AQP2 | Aquaporin 2 (collecting duct) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AQP3 | Aquaporin 3 (Gill blood group) | Blood group antigen proteins Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AQP4 | Aquaporin 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
AQP5 | Aquaporin 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AQP6 | Aquaporin 6, kidney specific | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ARFGEF1 | ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited) | | | | | | Expressed in all |
ARFGEF2 | ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited) | Disease related genes
| | | | | Expressed in all |
ARHGAP6 | Rho GTPase activating protein 6 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ARHGEF10L | Rho guanine nucleotide exchange factor (GEF) 10-like | | | | | | Expressed in all |
ARHGEF28 | Rho guanine nucleotide exchange factor (GEF) 28 | | | | | | Mixed |
ARL6IP5 | ADP-ribosylation-like factor 6 interacting protein 5 | Predicted membrane proteins
| | | | | Expressed in all |
ARMC10 | Armadillo repeat containing 10 | Predicted membrane proteins
| | | | | Expressed in all |
ARMCX1 | Armadillo repeat containing, X-linked 1 | Predicted membrane proteins
| | | | | Expressed in all |
ARSF | Arylsulfatase F | Predicted membrane proteins
| | | | | Tissue enhanced |
ART3 | ADP-ribosyltransferase 3 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ASAH1 | N-acylsphingosine amidohydrolase (acid ceramidase) 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ASCC3 | Activating signal cointegrator 1 complex subunit 3 | Enzymes
| | | | | Expressed in all |
ASGR2 | Asialoglycoprotein receptor 2 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
ASL | Argininosuccinate lyase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
ASPH | Aspartate beta-hydroxylase | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ASPHD1 | Aspartate beta-hydroxylase domain containing 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
ASPRV1 | Aspartic peptidase, retroviral-like 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
ATCAY | Ataxia, cerebellar, Cayman type | Disease related genes
| | | | | Tissue enriched |
ATG3 | Autophagy related 3 | | | | | | Expressed in all |
ATG4A | Autophagy related 4A, cysteine peptidase | Enzymes
| | | | | Expressed in all |